Top 5 Undervalued Stocks To Buy For 2014

The Bank of New York Mellon Corp. (1.0%) (BK)(BK - $35.29 - NYSE) is a global leader in providing financial services to institutions and individuals. The company operates in over one hundred markets worldwide and strives to be the global provider of choice for investment management and investment services. As of December 31, 2013, the firm had $27.6 trillion in assets under custody and $1.6 trillion in assets under management. Going forward, we expect BNY Mellon to benefit from rising global incomes and the cross border movement of financial transactions.From Mario Gabelli (Trades, Portfolio)'s Value 25 Fund first quarter 2014 shareholder commentary. Also check out: Mario Gabelli Undervalued Stocks Mario Gabelli Top Growth Companies Mario Gabelli High Yield stocks, and Stocks that Mario Gabelli keeps buying Currently 0.00/512345

Rating: 0.0/5 (0 votes)

Hot Media Companies For 2015: Schlumberger N.V.(SLB)

Schlumberger Limited, together with its subsidiaries, supplies technology, integrated project management, and information solutions to the oil and gas exploration and production industries worldwide. The company?s Oilfield Services segment provides exploration and production services; wireline technology that offers open-hole and cased-hole services; supplies engineering support, directional-drilling, measurement-while-drilling, and logging-while-drilling services; and testing services. This segment also offers well services; supplies well completion services and equipment; artificial lift; data and consulting services; geo services; and information solutions, such as consulting, software, information management system, and IT infrastructure services that support oil and gas industry. Its WesternGeco segment provides reservoir imaging, monitoring, and development services; and operates data processing centers and multiclient seismic library. This segment also offers variou s services include 3D and time-lapse (4D) seismic surveys to multi-component surveys for delineating prospects and reservoir management. The company?s M-I SWACO segment supplies drilling fluid systems to improve drilling performance; fluid systems and specialty tools to optimize wellbore productivity; production technology solutions to maximize production rates; and environmental solutions that manages waste volumes generated in drilling and production operations. Its Smith Oilfield segment designs, manufactures, and markets drill bits and borehole enlargement tools; and supplies drilling tools and services, tubular, completion services, and other related downhole solutions. The company?s Distribution segment markets pipes, valves, and fittings, as well as mill, safety, and other maintenance products. This segment also provides warehouse management, vendor integration, and inventory management services. Schlumberger Limited was founded in 1927 and is based in Houston, Texas.

Advisors' Opinion:

• [By Rich Duprey]

  Oil and gas industry services providers Cameron International (NYSE: CAM  ) and Schlumberger (NYSE: SLB  ) announced today that their�OneSubsea joint venture had received all required regulatory approvals and that they'll close on the JV on�June 30.

• [By Teresa Rivas]

  Schlumberger (SLB) was down in Thursday afternoon trading after a mixed first quarter.

  The oilfield giant said first quarter earnings were $1.59 billion, or $1.21 a share, up from 94 cents in the year-ago period and one penny ahead of estimates. Revenue rose 6.3% to $11.24 billion, just below the $11.49 billion analysts were expecting.

  The Middle East and Asia a was the strongest region, with sales up 19%, followed by North America, with 12%. Revenue edged ahead by 0.6% in Europe and Africa, while Latin America saw a 7.7% decline.

  Stephens analyst Michael Marino reiterated an Overweight rating on the stock: ��hile SLB’s geographically diversified footprint will likely limit exposure to the accelerating margin trends in North America this year, global oilfield spending continues to grow at a modest pace. Overall, we continue to see slow and steady revenue growth for the Company and solid incremental margins on higher deepwater mix, overall efficiency gains and potential pricing gains in North America.��/p>

  FBR Capital Markets��Thomas Curran and Juan Avendano reiterated their Outperform rating on the stock, noting the company�� share repurchases and reiteration of gudiance:

  Reveals several awards, confirming it claimed lion’s share of Pemex’s Mega-Tenders. In (1) Mexico, SLB officially announced that it won the largest combined award in Pemex’s recent Mega-Tender round: three multi-year IPM contracts worth, in aggregate, over $1.9B in revenues or nearly 50% of the spoils; (2) Norway, the Company inked a 5-year (plus two option periods of one year) IPM contract, of undisclosed value, with Det norske oljeselkap ASA for exploration drilling and development of the Ivar Aasen field in northern North Sea; (3) Australia, SLB completions signed a $40M contract with INPEX covering the upper and intermediate completions for its first 20 wells at the offshore Ichthys field; and (4) Brazil, SLB artificial lift won

• [By Jim Jubak]

  The company's January 10 announcement that it was lowering its guidance for the fourth quarter on declines in drilling activity in North America and Europe/Africa/Russia, has certainly contributed to weakness in the oil services sector and in the shares of competitors such as Schlumberger (SLB). With Schlumberger scheduled to report fourth quarter earnings on January 17, and with Baker Hughes scheduled for January 21, the question now is, ��as the lowered guidance from Baker Hughes de-risked the stocks in the sector or will there be enough disappointment in the actual reports to push the sector down farther?��/p>

Top 5 Undervalued Stocks To Buy For 2014: Tupperware Corporation(TUP)

Tupperware Brands Corporation operates as a direct seller of various products across a range of brands and categories through an independent sales force. The company engages in the manufacture and sale of kitchen and home products, and beauty and personal care products. It offers preparation, storage, and serving solutions for the kitchen and home, as well as kitchen cookware and tools, children?s educational toys, microwave products, and gifts under the Tupperware brand name primarily in Europe, Africa, the Middle East, the Asia Pacific, and North America. The company provides beauty and personal care products, which include skin care products, cosmetics, bath and body care, toiletries, fragrances, nutritional products, apparel, and related products principally in Mexico, South Africa, the Philippines, Australia, and Uruguay. It offers beauty and personal care products under the Armand Dupree, Avroy Shlain, BeautiControl, Fuller, NaturCare, Nutrimetics, Nuvo, and Swissgar de brand names. The company sells its Tupperware products directly to distributors, directors, managers, and dealers; and beauty products primarily through consultants and directors. As of December 26, 2009, the Tupperware distribution system had approximately 1,800 distributors, 61,300 managers, and 1.3 million dealers; and the sales force representing the Beauty businesses approximately 1.1 million. The company was formerly known as Tupperware Corporation and changed its name to Tupperware Brands Corporation in December 2005. The company was founded in 1996 and is headquartered in Orlando, Florida.

Advisors' Opinion:

• [By Dan Caplinger]

  Where growth will come from
  One area that Newell Rubbermaid still has to tap fully is emerging markets. The company has done a good job of expanding overseas, with 17% annual growth in Latin America. But with barely a quarter of its sales coming from outside the U.S. and Canada, the company has a lot further to go. Storage rival Tupperware (NYSE: TUP  ) gets fully 60% of its total revenue from emerging markets, and it too has seen impressive gains in South America as well as the Asia-Pacific region.

• [By James Brumley]

  CSCO stock might be one of the market’s dark-horse stories of 2014; the dividend yield is the icing on the cake.

  Dividend Stocks to Buy: Tupperware Brands (TUP)

  Dividend Yield: 3.2%

Top 5 Undervalued Stocks To Buy For 2014: Caterpillar Inc.(CAT)

Caterpillar Inc. manufactures and sells construction and mining equipment, diesel and natural gas engines, industrial gas turbines, and diesel-electric locomotives worldwide. It operates through three lines of businesses: Machinery, Engines, and Financial Products. The Machinery business offers construction, mining, and forestry machinery, including track and wheel tractors, track and wheel loaders, pipelayers, motor graders, wheel tractor-scrapers, track and wheel excavators, backhoe loaders, log skidders, log loaders, off-highway trucks, articulated trucks, paving products, skid steer loaders, underground mining equipment, tunnel boring equipment, and related parts. It also manufactures diesel-electric locomotives; and manufactures and services rail-related products and logistics services for other companies. The Engines business provides diesel, heavy fuel, and natural gas reciprocating engines for Caterpillar machinery, electric power generation systems, marine, petrol eum, construction, industrial, agricultural, and other applications. It offers industrial turbines and turbine-related services for oil and gas, and power generation applications. This business also remanufactures Caterpillar engines, machines, and engine components; and offers remanufacturing services for other companies. The Financial Products business provides retail and wholesale financing alternatives for Caterpillar machinery and engines, solar gas turbines, and other equipment and marine vessels, as well as offers loans and various forms of insurance to customers and dealers. It also offers financing for vehicles, power generation facilities, and marine vessels. The company markets its products directly, as well as through its distribution centers, dealers, and distributors. It was formerly known as Caterpillar Tractor Co. and changed its name to Caterpillar Inc. in 1986. Caterpillar Inc. was founded in 1925 and is headquartered in Peoria, Illinois.

Advisors' Opinion:

• [By Laura Brodbeck]

  Notable earnings released on Wednesday included:

  Caterpillar, Inc. (NYSE: CAT) reported third quarter EPS of $1.45 on revenue of $13.40 billion, compared to last year�� EPS 0f $2.54 on revenue of $16.44 billion. Boeing Company (NYSE: BA) reported EPS of $1.80 on revenue of $22.10 billion, compared to last year�� EPS 0f $1.35 on revenue of $20.01 billion. Bristol-Myers Squibb Company (NYSE: BMY) reported third quarter EPS of $0.46 on revenue of $4.07 billion, compared to last year�� EPS 0f $0.41 on revenue of $3.74 billion. Motorola, Inc (NYSE: MSI) reported third quarter EPS of $1.32 on revenue of $2.11 billion, compared to last year�� EPS 0f $0.84 on revenue of $2.15 billion. AT&T Inc. (NYSE: T) reported third quarter EPS of $0.66 on revenue of $32.20 billion, compared to last year�� EPS of $0.63 on revenue of $31.46 billion.

  Pre-Market Movers

• [By Paul Ausick]

  Big Earnings Movers: Broadcom Corp. (NASDAQ: BRCM) is down 2.9% at $26.36 after weak guidance. Cree Inc. (NASDAQ: CREE) is down 16.9% at $61.78 on even darker guidance. Caterpillar Inc. (NYSE: CAT) is down 6% at $83.82 on poor earnings and a softer outlook. Boeing Co. (NYSE: BA) is up 5.4% at $129.04 after posting a new 52-week high of $129.99 on good earnings and raised guidance.

• [By Ben Levisohn]

  On a day when almost nobody was trading, the major benchmarks eked out record highs anyway, behind gains in E.I. Du Pont De Nemours (DD), Caterpillar (CAT) and Walt Disney (DIS).

Top 5 Undervalued Stocks To Buy For 2014: Dollar Tree Inc.(DLTR)

Dollar Tree, Inc. operates discount variety stores in the United States and Canada. Its stores offer merchandise primarily at the fixed price of $1.00. The company operates its stores under the names of Dollar Tree, Deal$, Dollar Tree Deal$, Dollar Giant, and Dollar Bills. Its stores offer consumable merchandise, including candy and food, and health and beauty care, as well as household consumables, such as paper, plastics, household chemicals, in select stores, and frozen and refrigerated food; variety merchandise, which includes toys, durable housewares, gifts, party goods, greeting cards, softlines, and other items; and seasonal goods, such as Easter, Halloween, and Christmas merchandise. As of April 30, 2011, it operated 4,089 stores in 48 states and the District of Columbia, as well as 88 stores in Canada. The company was founded in 1986 and is based in Chesapeake, Virginia.

Advisors' Opinion:

• [By MONEYMORNING.COM]

  Retail Stocks to Watch No. 4: Family Dollar Stores Inc. (Nasdaq: FDO)
  One-year retail sales growth: 11.4%
  Total 2013 U.S. sales: $10.4 billion
  The poor economy has been good to Family Dollar, which has gained customers seeking the lowest possible prices. To accommodate such demand, FDO added 1,000 new items, many of them groceries. It also added 506 new stores to bring its total to 7,916. Although it has agreed to sell itself to Dollar Tree Inc. (Nasdaq: DLTR) for $8.5 billion, Dollar General Corp. (NYSE: DG) keeps making new offers. FDO is up 36.8% over the past three months as a result. FDO closed at $80.22.

• [By Terri Stridsberg]

  Dollar Tree (DLTR), has had a banner 2013, gaining 45.3% year-to-date, and tagging a new record high of $59.68. Nevertheless, short interest skyrocketed by close to 398% over the most recent reporting period, and now accounts for a healthy 6.7% of the equity's available float.

• [By David Kerr]

  On July 28, Dollar Tree (DLTR) announced that it will be buying rival Family Dollar for a total of $9.2 billion (including debt). Icahn had originally suggested that Family Dollar be bought out by leader Dollar General, but shortly after stated that the recent announcement of the retirement of Dollar General�� CEO would cause disruptions in his plan of merging the two companies. The announced deal gives Dollar Tree over 13,000 stores in the 48 states and Canada, as well as more than $18 billion in sales. This pushes Dollar Tree above and beyond major rival Dollar General, which last year had $17.5 billion in sales and 11,338 current locations. There has also been much talk about the impact this merger will have on the giant Wal-Mart (WMT), which generally focuses on low-income consumers by offering more items for under $1.

• [By Lawrence Meyers]

  As a convenience store, it doesn’t have direct competition from�Dollar Tree (DLTR) or Family Dollar (FDO) because these dollar stores aren�� exclusively focused on food (and they have no gasoline or cigarette sales), and they��e targeted at the folks who are trying to save money over convenience, not vice versa. The convenience angle is another reason why�Walmart (WMT) and Costco (COST)�aren’t competitors, since those behemoths are about a total shopping experience.

Replace Social Security or Fix It?

Investment advisors are familiar with the idea that past performance is not indicative of future returns.

And so it is in the realm of retirement income, according to financial economist Larry Kotlikoff, who argues that that a Social Security system that has by and large worked should not lead complacent Americans to assume its future viability.

That is one of the takeaway points from an online debate last week hosted by the National Academy of Social Insurance (NASI), a Washington, DC –based nonpartisan institute conducting research related to income security.

Both Kotlikoff and his opponent, Larry Thompson, a NASI founding board member, agree on the importance of social insurance (Kotlikoff is an academy member).

Indeed, Kotlikoff, the maverick Boston University economist who in 2012 sought the presidency on the Internet-based third party Americans Elect platform attests that Social Security represents a majority (55%) of the annual income of households headed by those 65 and older.

But Kotlikoff argues that Social Security is in “grave financial trouble,” worse than in 1983 when the Greenspan Commission reformed the system’s finances — indeed, “in worse shape than Detroit’s two pension systems, taken together,” Kotlikoff writes.

That is because the system is 32% underfunded, despite its nearly $3 trillion trust fund.

“In short, an immediate and permanent 32% hike in the Social Security payroll tax rate (from 12.4% to 16.4%, forever) is needed to pay the existing benefits. Alternatively, an immediate and permanent 23% cut in all OASDI benefits would provide long-term solvency,” Kotlikoff writes.

And while he does not think such drastic hikes or cuts are politically feasible, he argues that Social Security’s finances are just part of the system’s problems:

“Its Handbook has 2,728 complex rules, and its Program Operating Manual has thousands of even more complex rules to explain the Handbook's rules,” he writes.

This complexity, together with rising federal income taxes on Social Security benefits (which he attributes to a lack of inflation indexation), contribute to Americans’ confusion about the benefits to which they are entitled and age at which they should take them, thus possibly overestimating their retirement income.

And beyond solvency and complexity issues, Kotlikoff sees issues of inequity and inefficiency:

“Thanks to the system's spousal and survivor benefits, millions of workers pay Social Security taxes year after year and end up with no extra benefits. Indeed, a working spouse can end up with lower benefits than a spouse who never worked,” he adds, referring readers to a more detailed policy proposal he drafted as part of his 2012 campaign.

That proposal for replacing the U.S. pay-as-you-go Social Security system with individual contributions financed by mandatory contributions elicited skepticism from Larry Thompson, who argues that even Chile, which takes a similar approach, has recently modified its system away from exclusive reliance on private accounts.

Thompson argues that the key distinction between the current system and the one that Kotlikoff proposes is the former’s reliance on labor markets versus the latter’s dependence on capital markets.

“The major difference between the two approaches is that one sets pensions with reference to wage levels prevailing at retirement whereas the other establishes retirement incomes based on capital market returns over the course of the working life,” Thompson writes.

Noting that U.S. workers do rely on capital markets, to some extent, in their private IRAs, 401(k)s and the like, Thompson argues against forcing “everybody to put all of their retirement income eggs into the capital market basket.”

The NASI board member warns that the cost of transitioning Social Security to a private account system makes such a move impracticable.

For that reason, he challenges Kotlikoff and other critics of Social Security to instead turn their attention to underlying problems in our current system: “that workers (and/or their employers) are not contributing enough to their defined contribution accounts and that investment returns in these accounts underperform broad market averages due to high administrative charges and poor individual investment decisions.”

Reached by ThinkAdvisor, Kotlikoff demurred, arguing that all available evidence suggests Americans won’t voluntarily increase their savings to the extent needed to purchase income security in their retirement years.

“My plan forces people to save in the global financial system, but at no cost,” he says noting that the mandated 8% of income he advocates would be managed in a type of index fund whose expenses the government would alone bear.

“So I'm not leaving it up to workers to save on their own,” Kotlikoff says. Thompson could not be reached for comment.

---

Related on ThinkAdvisor:

Top 5 Valued Stocks To Watch For 2014

Building and aerospace technology conglomerate United Technologies Corp. (UTX) experienced surprisingly strong order growth in the Otis, Carrier, and Pratt & Whitney segments. Lower pension costs and synergies from the Goodrich acquisition bode well for future financial performance.

From Diamond Hill Capital (Trades, Portfolio) Large Cap Fund third quarter 2013 commentary.

Also check out: Diamond Hill Capital Undervalued Stocks Diamond Hill Capital Top Growth Companies Diamond Hill Capital High Yield stocks, and Stocks that Diamond Hill Capital keeps buying

Currently 4.50/512345

Rating: 4.5/5 (2 votes)

Subscribe via Email Subscribe RSS Comments Please leave your comment:
More GuruFocus Links Latest Guru Picks Value Strategies Warren Buffett Portfolio Ben Graham Net-Net Real Time Picks Buffett-Munger Screener Aggregated Portfolio Undervalued Predictable ETFs, Options Low P/S Companies Insider Trends 10-Year Financials 52-Week Lows Interactive Charts Model Portfolios DCF Calculator RSS Feed Monthly Newsletters The All-In-One Screener Portfolio Tracking Tool MORE GURUFOCUS LINKS Latest Guru Picks Value Strategies Warren Buffett Portfolio Ben Graham Net-Net Real Time Picks Buffett-Munger Screener Aggregated Portfolio Undervalued Predictable

Top 5 Industrial Conglomerate Stocks To Watch Right Now: Caterpillar Inc.(CAT)

Caterpillar Inc. manufactures and sells construction and mining equipment, diesel and natural gas engines, industrial gas turbines, and diesel-electric locomotives worldwide. It operates through three lines of businesses: Machinery, Engines, and Financial Products. The Machinery business offers construction, mining, and forestry machinery, including track and wheel tractors, track and wheel loaders, pipelayers, motor graders, wheel tractor-scrapers, track and wheel excavators, backhoe loaders, log skidders, log loaders, off-highway trucks, articulated trucks, paving products, skid steer loaders, underground mining equipment, tunnel boring equipment, and related parts. It also manufactures diesel-electric locomotives; and manufactures and services rail-related products and logistics services for other companies. The Engines business provides diesel, heavy fuel, and natural gas reciprocating engines for Caterpillar machinery, electric power generation systems, marine, petrol eum, construction, industrial, agricultural, and other applications. It offers industrial turbines and turbine-related services for oil and gas, and power generation applications. This business also remanufactures Caterpillar engines, machines, and engine components; and offers remanufacturing services for other companies. The Financial Products business provides retail and wholesale financing alternatives for Caterpillar machinery and engines, solar gas turbines, and other equipment and marine vessels, as well as offers loans and various forms of insurance to customers and dealers. It also offers financing for vehicles, power generation facilities, and marine vessels. The company markets its products directly, as well as through its distribution centers, dealers, and distributors. It was formerly known as Caterpillar Tractor Co. and changed its name to Caterpillar Inc. in 1986. Caterpillar Inc. was founded in 1925 and is headquartered in Peoria, Illinois.

Advisors' Opinion:

• [By John Divine]

  Lastly, Caterpillar (NYSE: CAT  ) stock was one of just seven decliners in the index, losing 1.5% today. Nearly 5% of Caterpillar's float is being sold short, making it the second most loathed stock in the Dow. Talks between Caterpillar and the United Steelworkers Union broke off late yesterday, showing the extent of the differences between the two sides as the 800 workers try to negotiate new contracts.

• [By Ben Levisohn]

  Caterpillar�� (CAT) mining business has already fallen from a peak of $21.2B to about $10.3B (-51%) whereas Joy Global�� combined businesses have fallen 32% with its OE business down 57% and its service business down about 7% from peak. The key question from investors is whether Joy Global’s revenue has further to fall, especially its service business which has held up better than expected in FY��4. Lack of visibility makes it hard to call, but certainly deteriorating US thermal coal conditions skew the risk to the downside.

• [By Jeremy Bowman]

  Elsewhere on the Dow, Caterpillar (NYSE: CAT  ) was the blue chips' biggest gainer as shares jumped 2.5%, seemingly on an interest rate cut by the Australian central bank. The rate cut could help spur capital investment in the Land Down Under, a mining-rich nation and a key market for Caterpillar.

• [By Dan Caplinger]

  On one hand, the obvious negative news for the Dow came from Caterpillar (NYSE: CAT  ) , which announced lower profit, reduced capital expenditures, and guidance for future earnings that came in at the lower end of its previous range. In particular, mining-equipment sales were a sore spot for the company, as falling prices for commodities have left miners in a much more precarious financial position that won't support as many large equipment purchases. Yet with all the news from China and elsewhere in recent months pointing toward a slowdown in industrial activity, Caterpillar's news wasn't surprising, even though the stock dropped nearly 1% after initially posting gains near the open.

Top 5 Valued Stocks To Watch For 2014: Tupperware Corporation(TUP)

Tupperware Brands Corporation operates as a direct seller of various products across a range of brands and categories through an independent sales force. The company engages in the manufacture and sale of kitchen and home products, and beauty and personal care products. It offers preparation, storage, and serving solutions for the kitchen and home, as well as kitchen cookware and tools, children?s educational toys, microwave products, and gifts under the Tupperware brand name primarily in Europe, Africa, the Middle East, the Asia Pacific, and North America. The company provides beauty and personal care products, which include skin care products, cosmetics, bath and body care, toiletries, fragrances, nutritional products, apparel, and related products principally in Mexico, South Africa, the Philippines, Australia, and Uruguay. It offers beauty and personal care products under the Armand Dupree, Avroy Shlain, BeautiControl, Fuller, NaturCare, Nutrimetics, Nuvo, and Swissgar de brand names. The company sells its Tupperware products directly to distributors, directors, managers, and dealers; and beauty products primarily through consultants and directors. As of December 26, 2009, the Tupperware distribution system had approximately 1,800 distributors, 61,300 managers, and 1.3 million dealers; and the sales force representing the Beauty businesses approximately 1.1 million. The company was formerly known as Tupperware Corporation and changed its name to Tupperware Brands Corporation in December 2005. The company was founded in 1996 and is headquartered in Orlando, Florida.

Advisors' Opinion:

• [By Johanna Bennett]

  Corporate earnings took a back seat today to the Fed�� latest policy decision. Still, quarterly financial results, and other news sent shares of McCormick & Co. (MKC) and Tupperware (TUP), falling during regular market hours�Here�� a rundown of several of today�� moves:

• [By Dan Caplinger]

  Where growth will come from
  One area that Newell Rubbermaid still has to tap fully is emerging markets. The company has done a good job of expanding overseas, with 17% annual growth in Latin America. But with barely a quarter of its sales coming from outside the U.S. and Canada, the company has a lot further to go. Storage rival Tupperware (NYSE: TUP  ) gets fully 60% of its total revenue from emerging markets, and it too has seen impressive gains in South America as well as the Asia-Pacific region.

• [By John Udovich]

  Everyone is familiar with�the Tupperware brand from�consumer products stock Tupperware Brands Corporation (NYSE: TUP) and you are probably familiar with the brands�of mid cap stock Jarden Corp (NYSE: JAH) along with small cap stocks Libbey Inc (NYSEMKT: LBY) and Lifetime Brands Inc (NASDAQ: LCUT); but what about the stocks themselves? Chances are, their brands or products are right under your nose at home and you probably don�� know anything about the mid cap or small cap stock behind them.

Top 5 Valued Stocks To Watch For 2014: Dollar Tree Inc.(DLTR)

Dollar Tree, Inc. operates discount variety stores in the United States and Canada. Its stores offer merchandise primarily at the fixed price of $1.00. The company operates its stores under the names of Dollar Tree, Deal$, Dollar Tree Deal$, Dollar Giant, and Dollar Bills. Its stores offer consumable merchandise, including candy and food, and health and beauty care, as well as household consumables, such as paper, plastics, household chemicals, in select stores, and frozen and refrigerated food; variety merchandise, which includes toys, durable housewares, gifts, party goods, greeting cards, softlines, and other items; and seasonal goods, such as Easter, Halloween, and Christmas merchandise. As of April 30, 2011, it operated 4,089 stores in 48 states and the District of Columbia, as well as 88 stores in Canada. The company was founded in 1986 and is based in Chesapeake, Virginia.

Advisors' Opinion:

• [By David Kerr]

  On July 28, Dollar Tree (DLTR) announced that it will be buying rival Family Dollar for a total of $9.2 billion (including debt). Icahn had originally suggested that Family Dollar be bought out by leader Dollar General, but shortly after stated that the recent announcement of the retirement of Dollar General�� CEO would cause disruptions in his plan of merging the two companies. The announced deal gives Dollar Tree over 13,000 stores in the 48 states and Canada, as well as more than $18 billion in sales. This pushes Dollar Tree above and beyond major rival Dollar General, which last year had $17.5 billion in sales and 11,338 current locations. There has also been much talk about the impact this merger will have on the giant Wal-Mart (WMT), which generally focuses on low-income consumers by offering more items for under $1.

• [By Paul Ausick]

  Big Earnings Movers: Target Corp. (NYSE: TGT) is down 3.5% at $64.19. Sears Holdings Corp. (NASDAQ: SHLD) is down 2.9% at $59.93 on a wider loss and tepid outlook. Green Mountain Coffee Roasters Inc. (NASDAQ: GMCR) is up 14.1% at $70.57 indicating that investors liked the results posted after markets closed on Wednesday. Dollar Tree Inc. (NASDAQ: DLTR) is down 4.5% at $56.28. Abercrombie & Fitch Inc. (NYSE: ANF) is down 0.1% at $34.97.

• [By Laura Brodbeck]

  Thursday

  Earnings Expected From: Salesforce.com (NYSE: CRM), Intuit (NASDAQ: INTU), Gap (NYSE: GPS), Dollar Tree (NASDAQ: DLTR), Hormel Foods (NYSE: HRL), Gamestop (NYSE: GME) Economic Releases Expected:  U.S. existing home sales, eurozone consumer confidence, U.S. manufacturing PMI, British retail sales, eurozone manufacturing PMI, eurozone services PMI, German manufacturing PMI, German services PMI, French manufacturing PMI, French services PMI

  Friday

• [By Ben Levisohn]

  Family Dollar (FDO) became a must-have after Carl Icahn announced a 9.4% stake in the bargain retailer–and so did competitors like Dollar General (DG) and Dollar Tree (DLTR).

Top 5 Valued Stocks To Watch For 2014: Schlumberger N.V.(SLB)

Schlumberger Limited, together with its subsidiaries, supplies technology, integrated project management, and information solutions to the oil and gas exploration and production industries worldwide. The company?s Oilfield Services segment provides exploration and production services; wireline technology that offers open-hole and cased-hole services; supplies engineering support, directional-drilling, measurement-while-drilling, and logging-while-drilling services; and testing services. This segment also offers well services; supplies well completion services and equipment; artificial lift; data and consulting services; geo services; and information solutions, such as consulting, software, information management system, and IT infrastructure services that support oil and gas industry. Its WesternGeco segment provides reservoir imaging, monitoring, and development services; and operates data processing centers and multiclient seismic library. This segment also offers variou s services include 3D and time-lapse (4D) seismic surveys to multi-component surveys for delineating prospects and reservoir management. The company?s M-I SWACO segment supplies drilling fluid systems to improve drilling performance; fluid systems and specialty tools to optimize wellbore productivity; production technology solutions to maximize production rates; and environmental solutions that manages waste volumes generated in drilling and production operations. Its Smith Oilfield segment designs, manufactures, and markets drill bits and borehole enlargement tools; and supplies drilling tools and services, tubular, completion services, and other related downhole solutions. The company?s Distribution segment markets pipes, valves, and fittings, as well as mill, safety, and other maintenance products. This segment also provides warehouse management, vendor integration, and inventory management services. Schlumberger Limited was founded in 1927 and is based in Houston, Texas.

Advisors' Opinion:

• [By Tyler Crowe]

  Surprisingly, our energy boom could help China, but not in the way you might think. The energy sector in the U.S. has been an incubator for innovative drilling techniques and technologies over the past few years. Now we have a near monopoly on the technology. Like the U.S., China has massive shale gas deposits, and the technology we possess could help them develop domestic sources and allow them to become more energy self-sufficient. We're starting to see it happen. Royal Dutch Shell (NYSE: RDS-A  ) has signed a deal with PetroChina (NYSE: PTR  ) to spend $1 billion a year to develop shale resources there. Also, fracking�specialists�Haliburton (NYSE: HAL  ) and Schlumberger (NYSE: SLB  ) are partnering with various Chinese companies to supply the country with hydraulic fracturing equipment and specialty fluids.�

• [By Ben Levisohn]

  Schlumberger�(SLB) has become the latest company to say that it will get hit by Russian sanctions on U.S. companies today.

  Sterne Agee’s Stephen Gengaro and Ivan Suleiman assess the potential impact:

  Schlumberger�expects that the economic sanctions in Russia will have a small financial impact on Schlumberger’s Russian operations. The company estimates that it could be up to $0.03 per share due to a short-term impact in operational efficiencies and costs in Russia.

  Schlumberger�remains confident that it can support its Russian clients without material disruption and will continue to work closely with its Russian customers.

  Although other large-cap service companies have exposure to Russia, we believe the effect is also minimal. Specifically, Weatherford (WFT) has noted that the Russian sanctions are not a concern as this is a very small portion of its business. In addition, this business is not impacted by the sanctions which are against Arctic and shale-related technologies. We estimate that Weatherford’s revenue in Russia is less than 3% of our estimated 2014 revenue.

  Other companies with large exposure to Russia include Nabors Industries (NBR), Halliburton (HAL) and Baker Hughes (BHI).

  RBC’s Kurt Hallead and Robert Pinkard use the occasion to assess the potential impact on�Schlumberger from Iraq instability:

  We estimate roughly $600mn in annual Iraq revenue ($0.06-$0.08 in EPS) for�Schlumberger with operating margins of ~20%. The situation due to political unrest is still very fluid in the country and EPS impact at this point is unknown.

  We are risk adjusting the next 6 quarters which we believe could be characterized by activity disruptions, higher security expenses and unabsorbed fixed costs.

  Hallead and Pinkard lowered their 2014 earnings-per share forecast to $5.56 from $5.64, and cut their 2015 prediction to $6.63 from $6.70. They did, however, leave their pric

• [By Joel South and Tyler Crowe]

  U.S. energy policy has been shaped by one critical event that happened 40 years ago this week: the OPEC oil embargo of 1973. Since then, the United States has embarked on an ambitious goal of drilling for our own oil and gas, as well as diversifying our energy portfolio. In this segment, Joel discusses why the shift away from OPEC domination could be a major opportunity for companies like Schlumberger (NYSE: SLB  ) and Kinder Morgan (NYSE: KMI  ) as well as whether OPEC is still the force it once was.

Best Beverage Companies To Invest In Right Now

In the early-morning hours of Thursday, reports surfaced that cola and snack giant�PepsiCo� (NYSE: PEP  ) �was in talks to buy beverage-industry disruptor�SodaStream� (NASDAQ: SODA  ) �for an unconfirmed price as high as $2 billion. After the news broke, shares of SodaStream jumped in premarket trading to nearly $96 a share but soon returned to earth after Pepsi CEO Indra Nooyi told CNBC the buyout rumor was "totally and completely untrue."

The rumored buyout news was initially broken by Israeli newspaper Calcalist, but it's still unclear what source provided the paper with details that now appear to be false. One thing is for certain, though: With recent data showing that short positions represent nearly 7 million shares, or 33% of shares of outstanding, shorts positions stand to lose a lot if shares climb higher from here.

All things considered, it could prove to be quite the volatile start of summer for SodaStream's stock price -- and an especially ugly one for investors shorting the stock.

Hot Sliver Companies To Own In Right Now: Beam Inc (BEAM)

Beam Inc. (Beam), incorporated on October 1, 1985, is a premium spirits company that makes and sells branded distilled spirits products in markets worldwide. The Company's principal products include bourbon whiskey, tequila, Scotch whisky, Canadian whisky, vodka, cognac, rum, cordials, and ready-to-drink pre-mixed cocktails. The Company's portfolio consists of brands the Company identifies as Power Brands, Rising Stars, Local Jewels and values Creators. The Power Brands are the Company's core brand equities, with global reach in premium categories. Rising Stars are smaller premium brands. Brands identified as Local Jewels act as Power Brands in local markets. Value Creators include a variety of brands. The Company's three reportable segments are the geographic regions, which consists of North America, Europe/Middle East/Africa (EMEA), and Asia-Pacific/South America (APSA). Each segment is engaged in the manufacture and sale of distilled spirits products. In May 2012, the Company acquired the Pinnacle vodka and Calico Jack rum brands and certain related assets (Pinnacle assets) from White Rock Distilleries, Inc. In January 2012, Beam acquired Cooley Distillery plc (Cooley), an Irish whiskey producer.

The Company�� Power Brands include Jim Beam Bourbon, Maker's Mark Bourbon, Sauza Tequila, Courvoisier Cognac, Canadian Club Whisky, Teacher's Scotch and Pinnacle Vodka. Beam�� Rising Stars brand includes Laphroaig Scotch, Knob Creek Bourbon, Basil Hayden's Bourbon, Kilbeggan Irish Whiskey, Cruzan Rum, Hornitos Tequila, Skinnygirl Cocktails and Sourz Liqueurs. The principal markets for the Company's spirits products are the United States, Australia, Germany, Spain, the United Kingdom, and Canada, and the Company continues to invest in emerging markets such as India, Brazil, Mexico, Russia, Central Europe, Asia, and other geographies.

During the year ended December 31, 2012, Power Brands, Rising Stars, and combined Local Jewels/Value Creators (including non-branded sales) repre! sent approximately 60%, 15%, and 25%, respectively, of the Company's net sales. Approximately 55% of its consolidated net sales were generated in the United States (based on country of destination) during 2012. In the United States, the Company sells its products either to wholesale distributors for resale to retail outlets or, in those states that control alcohol sales, to state governments who then sell them to retail customers and consumers. In the Company's other global markets, the Company uses a variety of route-to-market models, including third party distributors, global or regional duty free customers, other spirits producers and its joint ventures with The Edrington Group Ltd.

The Company competes with Bacardi Limited, Brown-Forman Corporation, Constellation Brands, Inc., Davide Campari Milano-S.p.A., Diageo PLC, Pernod Ricard S.A. and Remy Cointreau S.A.

Advisors' Opinion:

• [By Rich Duprey]

  That also means it won't buy rival whiskey distiller Beam (NYSE: BEAM  ) , a rumor that's floated around ever since it was spun off from Fortune Brands. Owning 23% of the North American whiskey market already with a portfolio consisting of brands that include Bushmills,�Crown Royal, and George Dickel (which uses the traditional "whisky" spelling), along with Scotch whiskys such as J&B, and, yes, Johnnie Walker, Diageo is tied for the top spot with Jack Daniels maker Brown-Forman (NYSE: BF-B  ) in the market.

• [By Jon C. Ogg]

  Beam Inc. (NYSE: BEAM) was downgraded to Hold from Buy based on valuation at Argus.

  Covidien Ltd. (NYSE: COV) was started as Buy at Needham & Co.

• [By Michael Calia]

  Activist investor William A. Ackman’s Pershing Square scaled back its stake in Beam Inc.(BEAM) to 8.3%, weeks after the alcoholic-beverage maker agreed to be taken over by Japanese company Suntory. The firm had been the largest shareholder in Beam, with a stake of about 13%.

• [By John Udovich]

  Suntory Beverage & Food Limited.�A soft drinks company with an integrated platform in four key regions (Japan, Europe, Oceania and Asia), Japan based Suntory Beverage & Food acquired�Beam Inc (NYSE: BEAM)�for $16 billion (a 25% premium) earlier this year (the sixth-largest ever in the beverage industry) to form the world's third largest premium spirits company. Beam Suntory�� brands or products include�the flagship Jim Beam bourbon and Yamazaki Japanese whisky, as well as world renown premium brands including Maker's Mark and Knob Creek bourbons, Hakushu and Hibiki Japanese whiskies, Teacher's, Laphroaig, and Bowmore Scotch whiskies, Canadian Club whisky, Courvoisier cognac, Sauza tequila, Pinnacle vodka and Midori liqueur. Beam Suntory generates annual worldwide sales of approximately $4.6 billion (excluding excise taxes). The deal was made in part because of Japan�� aging population means Japanese companies need to look overseas for growth while a strong Yen last year has helped to fuel acquisitions. It should be noted though that while Suntory Beverage & Food Limited�� stock does trade on the OTC in the USA, volume over the past two months has ranged from a low of 9,740 shares to a high of 761,630 shares. On Tuesday, Suntory Beverage & Food Limited rose 1.42% to $19.33 (STBFY has a 52 week trading range of $15.25�to $19.43 a share) for a market cap of $11.78 billion plus the stock is 18.9% since the start of the year and up 13.7% since October 2013.

Best Beverage Companies To Invest In Right Now: PureSafe Water Systems Inc (PSWS)

PureSafe Water Systems, Inc., incorporated on March 9, 1987, is engaged in the design and development of its technology to be used in the manufacture and sale of water purification systems both in and outside the United States. The Company�� PureSafe First Response Water System (PureSafe FRWS) is self-contained and purifies most types of contaminated fresh or service water, including seawater that may be found at a first response emergency site. This system is mobile, by helicopter or transported by truck.

The PureSafe FRWS utilizes its technology which consists of water extraction boom that extracts water from the ocean, streams, ponds, pools of floodwater or a failed municipal distribution system. The extracted water is then treated by the application of advanced water treatment technologies which employ multiple stage filtration, multiple stage sanitation (including ozone, chlorine and ultraviolet purification techniques), reverse osmosis membranes, mineralization and final polishing to meet the standard drinking water requirements of the United States Environmental Protection Agency (the EPA). Its 2nd prototype (FRWS unit) unit can produce EPA compliant drinking from contaminated fresh or surface water at the rate of 30,000 gallons per day, to provide drinking water to 45,000 people. The unit has a built in generator and water bagging capability at the rate of 30,000 and a half liters bags of water per day

The Company competes with GE, Siemens, Severn Trent, Ecospheres Technology, Lenntech, Testa/Viwa, Lifekeeper, Mobile MaxPure, Bi Pure Water, Rodi, Global Water Group, Nirosoft, LifeStream, and Aquapura Tempest.

Advisors' Opinion:

• [By John Udovich]

  Small cap Sodastream International Ltd (NASDAQ: SODA), an Israeli based developer, manufacturer and marketer of�home beverage carbonation systems, has attracted its share of hype over both its products and its stock, but could other small cap water stocks like Primo Water Corporation (NASDAQ: PRMW), Puresafe Water Systems Inc (OTCMKTS: PSWS) and Alkaline Water Company Inc (OTCBB: WTER) attract a similar following? After all, Sodastream International has managed to create a significant amount of buzz from consumers, investors and even short sellers because it�� the�world's largest manufacturer, distributor and marketer of home carbonation systems as its�brands are sold in over 60,000 retail stores in 45 countries. Sodastream International is also up 45.7% since the start of the year, up 70.2% over the past year and up 99.3% since November 2010, but shares did spike up to the $75 level in the middle of 2011 and now trade at the $63 level.

Best Beverage Companies To Invest In Right Now: Cott Corp (COT)

Cott Corporation (Cott), incorporated on December 31, 2006, is a producers of beverages on behalf of retailers, brand owners and distributors. The Company�� product lines include carbonated soft drinks (CSDs), 100% shelf stable juice and juice-based products, clear, still and sparkling flavored waters, energy products, sports products, new age beverages, and ready-to-drink teas, as well as alcoholic beverages for brand owners. The Company operates in five segments: North America (which includes the United States operating segment and Canada operating segment), the United Kingdom (which includes its United Kingdom reporting unit and its Continental European reporting unit), Mexico, Royal Crown International (RCI) and All Other. The Company markets or supplies over 500 retailer, licensed and Company-owned brands in its four core geographic segments. In March of 2012, its U.K. reporting segment acquired a beverage and wholesale business based in Scotland.

Advisors' Opinion:

• [By kcpl]

  It wasn�� a good quarter for Cott Corporation (COT) as the company had trouble with its volumes. Cott Corporation engages in the production and distribution of retailer brand beverages in North America and globally. It offers carbonated soft drinks, flavored waters, energy-related drinks, juice, juice-based products, bottled water and ready-to-drink teas. It primarily serves grocery, mass-merchandise, drugstore, wholesale and convenience store chains.

Best Beverage Companies To Invest In Right Now: Brown-Forman Corp (BFB)

Brown-Forman Corporation, incorporated on October 19, 1933, primarily manufactures, bottles, imports, exports, markets, and sells a variety of alcoholic beverage brands. The Company�� principal brands are Jack Daniel�� Tennessee Whiskey, Jack Daniel�� Tennessee Whiskey, Pepe Lopez Tequilas, Jack Daniel�� Single Barrel, Woodford Reserve Bourbons, Jack Daniel�� Ready-to-Drinks, Canadian Mist Blended Canadian Whiskies, Jack Daniel�� Tennessee Honey, Chambord Liqueur, Jack Daniel�� Winter Jack Chambord Vodka, Gentleman Jack, Collingwood Canadian Whisky, Southern Comfort, Early Times Bourbon, Southern Comfort Ready-to-Drinks, Early Times flavored line extensions, Southern Comfort flavored line extensions, Early Times Kentucky Whisky, Finlandia Vodkas, Korbel California Champagnes, Finlandia Ready-to-Drinks, Little Black Dress Vodkas, Antiguo Tequila, Maximus Vodkas, el Jimador Tequilas, Old Forester Bourbon, el Jimador New Mix Ready-to-Drinks, Sonoma-Cutrer Wines, Herradura Tequilas, and Tuaca Liqueur.

The Company�� products are sold in more than 150 countries around the world. The Company�� international markets include Australia, the United Kingdom, Mexico, Germany, Poland, France, Russia, Japan, Turkey, Canada, Spain, Czech Republic, South Africa, Brazil and Italy.

The Company competes with Bacardi Limited, Beam Inc., Davide Campari-Milano S.p.A., Diageo plc, LVMH Moet Hennessy Louis Vuitton S.A., Pernod Ricard S.A., and Remy Cointreau S.A.

Advisors' Opinion:

• [By Seth Jayson]

  Brown-Forman (NYSE: BFB  ) reported earnings on June 5. Here are the numbers you need to know.

  The 10-second takeaway
  For the quarter ended April 30 (Q4), Brown-Forman met expectations on revenues and beat expectations on earnings per share.

Best Beverage Companies To Invest In Right Now: MOJO Organics Inc (MOJO)

MOJO Organics, Inc., incorporated on August 2, 2007, engages in product development, production, marketing and distribution of CHIQUITA TROPICALS. CHIQUITA TROPICALS are a 100% fruit juice, produced under license agreement from Chiquita Brands. The Company�� product flavors include Banana Strawberry, Mango, Passion Fruit, and Pineapple.

The Company�� juices are produced without preservatives and without added sugar. The Company produces and packages the CHIQUITA TROPICALS products through production facilities and services on a contract basis.

The Company competes with The Coca-Cola Company and PepsiCo, Inc.

Advisors' Opinion:

• [By Lisa Levin]

  Catalog & Mail Order Houses: The industry gained 1.13% by 10:15 am. The top performer in this industry was Mojo Organics (OTC: MOJO), which gained 6.6%. Mojo Organics shares have jumped 361.54% over the past 52 weeks, while the S&P 500 index has gained 16.18% in the same period.

Best Beverage Companies To Invest In Right Now: Frontier Beverage Company Inc (FBEC)

Frontier Beverage Company, Inc., incorporated on November 18, 2002, is in the business of development, marketing and distribution of New Age/Alternative Beverages and snack products. New Age/Alternative Beverages is an industry categorization for a group of products that include energy drinks/infused water, fruit juices and drinks, dairy and dairy substitutes, and bottled/canned teas. In October 2013, the Company announced that it has acquired holding company 22 Social Club Productions Inc. and its subsidiaries Blue 22 Entertainment.

The Company markets, sells and maintain inventories of Innovative Beverage Group Holdings, Inc. known as UnWind Ultimate Relaxation (UnWind) in Citrus Orange, Goji Grape and Pom Berry flavors in cases of twelve, 12-ounce slim cans. In addition to 12-ounce cans of UnWind, the Company also developed and test marketed a product line known as Bulldozer, which was a concentrated version of the canned UnWind beverage packaged in three-ounce containers. The Company's point-of-sale line includes posters, statics, info cards, suction racks and suction stickers.

Advisors' Opinion:

• [By Peter Graham]

  Small cap stocks Frontier Beverage Company Inc (OTCMKTS: FBEC), IMD Companies Inc (OTCMKTS: ICBU) and Dmh International Incorporated (OTCBB: DMHI) were all mimicking the Titanic last Friday by sinking 41.18%, 32.5% and 28.16%, respectively, last Friday. Moreover, all three of these stocks have been the subject of paid promotions or investor relation campaigns. With the promotions in mind, is it to late to dump these small cap stocks or will this week present a buying opportunity? Here is a closer look:

  Frontier Beverage Company Inc (OTCMKTS: FBEC) Announces Changes and Proposed Plans

  Small cap Frontier Beverage Company is a diversified holding company with the following subsidiaries: 22 Social Club Productions, Blue 22 Entertainment and App Quest LLC. On Friday, Frontier Beverage Company sank 41.18% to $0.005 for a market cap of $93,905 plus FBEC is down 77.5% since last March and down 99.2% over the past five years according to Google Finance.

5 Best Biotech Stocks To Buy Right Now

Popular Posts: Hottest Energy Stocks Now – HK QEP CLMT SDRL13 “Triple A” Stocks to Buy7 Biotechnology Stocks to Buy Now Recent Posts: Hottest Financial Stocks Now – ASPS MBI SF LPLA Biggest Movers in Healthcare Stocks Now – ALXN PODD ISIS REGN Hottest Technology Stocks Now – SATS WDAY P CGNX View All Posts

This week, these five stocks have the worst ratings in Operating Margin Growth, one of the eight Fundamental Categories on Portfolio Grader.

Neurocrine Biosciences, Inc. () is focused on the discovery and development of therapeutics for neuropsychiatric, neuroinflammatory, and neurodegenerative diseases and disorders. NBIX gets F’s in Earnings Growth, Analyst Earnings Revisions, Equity and Sales Growth as well. .

10 Best Gas Stocks For 2015: ImmunoCellular Therapeutics Ltd (IMUC)

ImmunoCellular Therapeutics, Ltd., incorporated on March 20, 1987, is a clinical-stage biotechnology company. The Company is engaged in developing immune-based therapies for the treatment of cancers, such as brain, ovarian and other solid tumors. Immunotherapy is an approach to treat cancer in which a patient�� own immune system is stimulated to target tumor antigens, which are molecular signals that the immune system uses to identify foreign bodies. The Company�� products include ICT-107, ICT-140, ICT-120, ICT-109 and DIAAD. ICT-107, the pipeline product, is a Phase II therapeutic dendritic cell (DC) vaccine for the treatment of glioblastoma multiforme (GBM), the common and lethal type of brain cancer. ICT-107 is designed to activate a patient�� immune system to target six different tumor-associated antigens. In February 2012, it acquired a world-wide license from the University of Pennsylvania and The John Hopkins University (JHU).

The Company in addition to ICT-107, is also developing other therapeutic DC vaccines: ICT-140 for ovarian cancer and ICT-121 for recurrent GBM. ICT-140 targets seven tumor-associated antigens expressed on ovarian cancer cells. ICT-107 is a DC vaccine that targets six different tumor-associated antigens that are found on patients��tumor cells; four of the six antigens are expressed on CSCs. The therapeutic vaccine is used subsequent to conventional therapy or concomitantly with chemotherapy in patients with newly diagnosed GBM. ICT-140 is a DC vaccine that targets seven different ovarian cancer antigens. ICT-121 is a DC vaccine that targets CD133 antigens; it has the potential to be a universal cancer vaccine because CD133 is widely expressed on CSCs from a majority of cancers. Data from this small study demonstrated that ICT-109 had a statistically ability to discriminate between cancerous and non-cancerous samples, suggesting the potential to detect pancreatic and lung cancer in plasma and serum study sets. The DIAAD (differential immunization for an! tigen and antibody discovery) platform it acquired from Molecular Discoveries utilizes immunological tolerization to accelerate the discovery of the molecular differences between diseased cells and their normal counterparts. The monoclonal antibodies produced by DIAAD provide the basis for the discovery and development of its potential diagnostic and therapeutic products.

The Company competes with Dendreon, Oncothyreon, Galena, Bavarian Nordic and Immunovaccine, Northwest Biotherapeutics, Prima Biomed, DCPrime, Roche/Genentech, Seattle Genetics, Bristol-Myers Squibb and Immunogen.

Advisors' Opinion:

• [By Monica Gerson]

  ImmunoCellular Therapeutics (NYSE: IMUC) dropped 11.05% to $1.3699. ImmunoCellular's trailing-twelve-month ROE is -59.80%.

  Posted-In: market losersNews Movers & Shakers Intraday Update Markets

5 Best Biotech Stocks To Buy Right Now: CEL-SCI Corp (CVM)

CEL-SCI Corporation (CEL-SCI), incorporated on March 22, 1983, is engaged in the business of Multikine cancer therapy; New cold fill manufacturing service to the pharmaceutical industry, and ligand epitope antigen presentation System (LEAPS) technology, with two products, hemagglutinin type 1 and neuraminidase type 1 (H1N1) swine flu treatment for H1N1 hospitalized patients and CEL-2000, a rheumatoid arthritis treatment vaccine.

Multikine

CEL-SCI's Multikine, is being developed for the treatment of cancer. It is a cancer immunotherapy drugs called Combination Immunotherapy because it combines active and passive immunity in one product. It is the only cancer immunotherapy that both kills cancer cells and activates the general immune system to destroy the cancer. Multikine target the tumor micro-metastases for treatment failure. Multikine is also applicable in many other solid tumors.

New Manufacturing Facility

CEL-SCI's facility manufactures Multikine for CEL-SCI's Phase III clinical trial. CEL-SCI offers the use of the facility as a service to pharmaceutical companies and others, particularly those that need to fill and finish their drugs in a cold environment. Fill and finish is the process of filling injectable drugs in a sterile manner.

LEAPS

CEL-SCI's patented T-cell Modulation Process uses heteroconjugates to direct the body to choose a specific immune response. The heteroconjugate technology, referred to as LEAPS, is intended to stimulate the human immune system to fight bacterial, viral and parasitic infections, as well as autoimmune, allergies, transplantation rejection and cancer. Administered like vaccines, LEAPS combines T-cell binding ligands with small, disease associated and peptide antigens.

Using the LEAPS technology, CEL-SCI has created a peptide treatment for H1N1 (swine flu) hospitalized patients. This LEAPS flu treatment is designed to focus on the conserved, non-changing epitopes of the di! fferent strains of Type A Influenza viruses, including swine, avian or bird, and Spanish Influenza. CEL-SCI's LEAPS flu treatment contains epitopes.

Advisors' Opinion:

• [By Bryan Murphy]

  Look out AbbVie Inc. (NYSE:ABBV), and Gilead Sciences, Inc. (NASDAQ:GILD), you may want to look over your shoulder as well. There's a new immunology player coming to town, and its name is CEL-SCI Corporation (NYSEMKT:CVM). Yes, AbbVie may be the name behind blockbuster drug Humira - with nearly $10 billion in sales in 2012 - while Gilead Sciences is saving HIV patients' lives with immunological therapies Stribild and Complera. But, small cap company CEL-SCI may be closer to launching its own immunology drug sooner than most investors realize.

5 Best Biotech Stocks To Buy Right Now: Neurocrine Biosciences Inc.(NBIX)

Neurocrine Biosciences, Inc. engages in the discovery, development, and commercialization of drugs for the treatment of neurological and endocrine-related diseases and disorders in the United States. It develops drugs for endometriosis, stress-related disorders, pain, tardive dyskinesia, uterine fibroids, diabetes, insomnia, and other neurological and endocrine-related diseases and disorders. The company?s products in clinical development include Elagolix, a Phase II drug for endometriosis; Vesicular Monoamine Transporter 2 Inhibitor (VMAT2), a Phase II drug for movement disorders; CRF2 Peptide Agonist, a Phase II drug for cardiovascular diseases; CRF1 Antagonist, a Phase II drug for stress-related disorders; and Elagolix, a Phase II drug for uterine fibroids. Its research programs comprise G Protein-Coupled Receptor 119 (GPR119) for type II diabetes; VMAT2 for schizophrenia; GnRH Antagonists for men?s and women?s health, and oncology; Antiepileptic Drugs for epilepsy, essential tremor, and pain; and G Protein-Coupled Receptors for other conditions. The company has collaborations with GlaxoSmithKline to develop and commercialize CRF antagonists for psychiatric, neurological, and gastrointestinal diseases; Dainippon Sumitomo Pharma Co. Ltd. to develop and commercialize Indiplon in Japan; Abbott International Luxembourg S.�r.l. to develop and commercialize elagolix and GnRH antagonists for women?s and men?s health indications; and Boehringer Ingelheim International GmbH to research, develop, and commercialize small molecule GPR119 agonists for the treatment of type II diabetes and other indications. Neurocrine Biosciences, Inc. was founded in 1992 and is headquartered in San Diego, California.

Advisors' Opinion:

• [By Ben Levisohn]

  Yes, say the folks at Nomura, who recommend buying�Celgene (CELG), Receptos
  (RCPT), Gilead Sciences (GILD), Neurocrine Biosciences (NBIX), and Alexion Pharmaceuticals (ALXN), in that order. Analyst M. Ian Somaiya and team explain why:

• [By John Udovich]

  Yesterday, small cap biopharmaceutical stock Neurocrine Biosciences, Inc (NASDAQ: NBIX) surged 89.69% after announcing positive results for its VMAT2 inhibitor NBI-98854 as a treatment for tardive dyskinesia, meaning investors late to the party or those already in should take a closer look at the stock along with its performance verses that of biotech ETFs like the iShares NASDAQ Biotechnology Index ETF (NASDAQ: IBB) and SPDR S&P Biotech ETF (NYSEARCA: XBI).

5 Best Biotech Stocks To Buy Right Now: BioTime Inc (BTX)

BioTime, Inc., incorporated on November 30, 1990, is a biotechnology company focused on the emerging field of regenerative medicine. Its commercial strategy is focused on its line of research products, such as ACTCellerate cell lines and associated ESpan culture media, HyStem hydrogels, human embryonic stem (hES) cell lines, and royalties from Hextend. Its focus is to provide regenerative therapies for age-related degenerative diseases. In January 2011, the Company acquired the assets of Cell Targeting, Inc. (CTI), a biotechnology company focused on methods of painting molecules on the surface of cells, which in turn causes the cells to adhere to particular tissues, such as those afflicted with disease. On March 21, 2011, the Company acquired Glycosan BioSystems, Inc. (Glycosan) through a merger of Glycosan with OrthoCyte Corporation (OrthoCyte). Through the merger, OrthoCyte acquired all of Glycosan�� assets, including Glycosan�� Hystem hydrogel product line. In March 2011, the Company entered into an agreement with XenneX, Inc., pursuant to which it organized LifeMap Sciences, Inc. (LifeMap), a subsidiary formed to advance the development and commercialization of its human embryonic stem (hES) cell data base. In August 2011, four hES cell lines (ESI-035, ESI-049, ESI-051 and ESI-053) developed by its subsidiary ES Cell International (ESI) were approved by the National Institutes of Health (NIH) for inclusion in the NIH Human Embryonic Stem Cell Registry. In May 2012, the Company acquired XenneX, Inc., through a merger of XenneX into LifeMap Sciences. In September 2012, the Company formed a wholly owned subsidiary, BioTime Acquisition Corporation. In October 2013, Geron Corporation announced the closing of the transaction to divest the Company's stem cell assets to Asterias Biotherapeutics, Inc., a subsidiary of BioTime, Inc.

HyStem is a biomaterial, which mimics the human extracellular matrix, which is the network of molecules surrounding cells in organs and tissues which is essent! ial to cellular function. Its HyStem hydrogels may have other applications when combined with the diverse and scalable cell types its scientists have isolated from hES cells. HyStem-Rx is a clinical grade formulation of HyStem-C, a biocompatible, implantable hyaluronan and collagen-based matrix for cell delivery in human clinical applications. Its subsidiary, OncoCyte Corporation, is developing PanC-Dx, a non-invasive blood-based cancer screening test designed to detect the presence of various human cancers, including cancers of the breast, lung, bladder, uterus, stomach, and colon, during routine check -ups. BioTime Asia, Limited (BioTime Asia) sells products for research use and may develop therapies to treat cancer and neurological and orthopedic diseases in Asia. OrthoCyte Corporation (OrthoCyte) is developing therapies to treat orthopedic disorders, diseases and injuries. ReCyte Therapeutics, Inc. (ReCyte Therapeutics) is developing therapies for age-related cardiovascular and blood disorders. Cell Cure Neurosciences Ltd. (Cell Cure Neurosciences), is a biotechnology company focused on developing stem cell-based therapies for retinal and other neurological disorders, including the development of retinal pigment epithelial (RPE) cells for the treatment of age-related macular degeneration. LifeMap Sciences, Inc. (LifeMap) is advancing the development and commercialization of our embryonic stem cell database and plans to make the database available for the marketing of research products and for use by stem cell researchers at pharmaceutical and biotechnology companies and other institutions via paid subscriptions or on a fee per use basis.

The Company�� blood plasma expander product, Hextend, is a physiologically balanced intravenous solution used in the treatment of hypovolemia, a condition caused by low blood volume, often from blood loss during surgery or injury. Hextend maintains circulatory system fluid volume and blood pressure, and keeps vital organs perfused during surgery and t! rauma car! e. Hextend is manufactured and distributed in the United States by Hospira, Inc., and in South Korea by CJ CheilJedang (CJ), under license from it.

Human Embryonic Stem Cell Lines for Research Use

Combined with the Company�� ACTCellerate technology, it derives of a range of markets human embryonic progenitor cells (hEPCs). ESI�� six current good manufacturing practices (cGMP) hES cell lines have been approved by the NIH for inclusion in the Human Embryonic Stem Cell Registry, which renders those cell lines eligible for use in federally funded research. The ESI hES cell lines are available for purchase through www.biotimeinc.com. It also markets hEPCs developed using ACTCellerate technology. Its hEPCs are also available for sale through www.biotimeinc.com. It derived the complete genome sequence of five of the ESI hES cell lines to facilitate the development of products derived from these cell lines. It has made these GMP-grade cell lines, along with certain documentation and complete genomic deoxyribonucleic acid (DNA) sequence information, available for sale.

The Company offers human stem cell products and technology that can be used by researchers at universities and at companies in the bioscience and biopharmaceutical industries. It has developed research and clinical grade hES cell lines, which it markets for both basic research and therapeutic product development. It also markets human embryonic progenitor cell (hEPCs) developed using ACTCellerate technology. These hEPCs are purified lineages of cells, which are intermediate in the developmental process between embryonic stem cells and fully differentiated cells. The ACTCellerate cell lines are also available for purchase through http://www.biotimeinc.com.

Human Embryonic Progenitor Cells

Through the Company�� subsidiary ReCyte Therapeutics, it had a license from Advanced Cell Technology, Inc. (ACT) to use ACTCellerate technology, and the rights to market more than 200 human c! ell types! made using that process. ACTCellerate allows the rapid isolation of hEPCs, which are cells that are intermediate in the developmental process between embryonic stem cells and fully differentiated cells.

Through an agreement with ReCyte Therapeutics, Millipore Corporation became a global distributor of ACTCellerate hEPC lines. In addition to the products, which it is co-marketing with Millipore, it offers 92 other ACTCellerate hEPC lines for purchase at www.biotimeinc.com. Through its subsidiary LifeMap, it provides online biomedical database services to increase awareness of molecular markers and diverse cell types comprising its ACTCellerate hEPC lines. It also focuses to market additional cell types manufactured with its PureStem technology. PureStem cell lines are produced by the exogenous expression of specific transcription factors, which regulate the differentiation of cell types from hES or induced pluripotent stem (iPS) cells. BioTime Asia has an agreement with Shanghai Genext Medical Technology Co., Ltd. to sell ACTCellerate hEPC lines and related ESpan growth media to the medical and biological research communities in China, Taiwan, Hong Kong, and Macau on an exclusive basis. The marketing agreement includes provisions for an initial stocking inventory and annual milestones to maintain exclusivity. The Company�� California Institute of Regenerative Medicine (CIRM)-funded research addresses the need for industrial scale production of purified therapeutic cells.

hES Cells Carrying Genetic Diseases

The Company focuses to add to its product line muscle progenitor cells produced from five hES cell lines carrying genes for Duchenne muscular dystrophy, Emery-Dreifuss muscular dystrophy, spinal muscular atrophy Type I, facioscapulohumeral muscular dystrophy 1A, and Becker muscular dystrophy. It obtained the diseased hES cell lines from Reproductive Genetics Institute (RGI).

ESpan Cell Growth Media

The Company is marketing a range of! cell-gro! wth media products called ESpan. These growth media are optimized for the growth of hEPC types. Cells need to be propagated in liquid media, in both the laboratory setting, where basic research on stem cells is performed, and in the commercial sector. Its ESpan products are marketed through Millipore and Genext.

ESpy Cell Lines

The Company focuses for development of ESpy cell lines. The ability of the ESpy cells to emit light will allow researchers to track the location and distribution of the cells in both in vitro and in vivo studies.

HyStem Hydrogel for Research and HyStem-Rx for Cell Delivery Medical Devices

HyStem is a patented biomaterial that mimics the ECM, the network of molecules surrounding cells in organs and tissues that is essential to cellular function. Its HyStem technology forms the foundation for stem cell delivery products in both the adult and embryonic stem cell marketplace, including products manufactured using its ACTCellerate technology. As an injectable product, HyStem-Rx may address need in cosmetic and reconstructive surgeries and other procedures by transplanting adipose derived cells or other adult stem cells. The transfer of cells in HyStem-Rx localizes the transplanted cells at the intended site and by providing a three-dimensional scaffold upon which cells can rebuild normal tissue. HyStem-Rx may support other emerging cell and tissue transplant therapies, such as those derived from hES and iPS cells, in addition to its potential application in the treatment of a range of conditions such as osteoarthritis, brain tumors, stroke, bone fracture, and wounds.

Advisors' Opinion:

• [By Brian Pacampara]

  Based on the aggregated intelligence of 180,000-plus investors participating in Motley Fool CAPS, the Fool's free investing community, biotechnology company BioTime (NYSEMKT: BTX  ) has received the dreaded one-star ranking.

• [By John Udovich]

  Stem cell stocks have not exactly been the best performers lately in part because the controversy over their use has died down over the years while major breakthroughs have been few or far between, but the industry along with small cap stem cell stocks Pluristem Therapeutics Inc (NASDAQ: PSTI), BioTime, Inc (NYSEMKT: BTX) and BioRestorative Therapies (OTCBB: BRTX) are still quietly producing their share of news or minor breakthroughs worth taking note of. Just consider the following stem cell news or news from small cap players in the sector:

Market Wrap-up for Jan. 3 – Dogs of the Dow: Which Ones Will Bite?

A popular investing strategy known as the “Dogs of the Dow” involves buying the top 10 highest-yielding Dow 30 components at the beginning of each year. Let’s take a look at this year’s “Dogs” and examine how worthy they are of your investment dollars.

First, a Quick Recap

Historically, buying the Dogs of the Dow has made for mixed results. From 1957 to 2003, for example, the Dogs outperformed the markets by around three percentage points annually. In contrast, the strategy trailed the wider markets considerably from 2001 to 2010.

In 2013, buying the Dogs netted about a 30% return, matching the S&P’s return gains for the same period, but beating the overall Dow 30′s return of around 26%. Minus Hewlett-Packard’s (HPQ) massive 96% run-up in 2013, however, last year’s Dogs would have underperformed the wider markets. With some significant price moves since last year, and three new recent additions to the Dow 30 (along with three corresponding subtractions from the list), this year’s Dogs look a bit different – although the top four spots remain unchanged.

2014 Dogs of the Dow: One-Sentence Takes

1. AT&T Inc. (T) – Yielding a healthy 5.3%, this telecom giant offers by far the best yield of the group, but investors should curb their expectations for any significant price growth.

2. Verizon Communications (VZ) – A stable business and a yield of 4.3% should continue to attract income investors in 2014.

3. Intel Corporation (INTC) – Five years ago, who would’ve thought Intel would get this serious about its dividend policy (currently yielding 3.7%)?

4. Merck & Co. (MRK) – Mega-cap pharma play could be one blockbuster new drug away from breaking out, but its 3.6% yield is pretty nice in the mean time.

5. Pfizer Inc. (PFE) – It’s no coincidence that PFE and its 3.4% yield sit right next to rival Merck on this list.

6. McDonald’s Corp. (MCD) – Without a popular new product to lure customers in, MCD’s 3.3% yield may not be enough to change its “dead money” status from last year.

7. General Electric (GE) – Its yield of 3.3% is in-line with historical norms, and the company boosted its payout by 18% last month.

8. Chevron Corp (CVX) – This new Dog has raised its dividend significantly in recent years, and its price performance has been fantastic, too.

Top 10 Insurance Companies To Watch For 2015

9. Cisco Systems (CSCO) – Another new Dog on the block, Cisco has adopted a high dividend strategy because its growth days are clearly over.

10. Microsoft Corporation (MSFT) – Three tech stocks in the Dogs list this year – my, how times have changed.

Today in the Markets

Following yesterday’s pullback on the first trading day of 2014, the markets got off on a more bullish foot this morning. While many Asian markets posted big losses last